Hyderabad Univarsity inks MoU with Natco Pharma for research
University of Hyderabad (UoH) has signed an
MoU with Natco Pharma for carrying out advance research in the areas of
discovery of novel drugs and their delivery systems among others.
According to a release issued by the
university today, the research includes nano formulations of new chemical entities and novel
biotechnological processes for specific products with potential commercial
importance.
Both the parties will promote cooperation in
academic exchange, research and development collaborations, training and
research in the areas of biotechnology, pharmacology, toxicology, pharmaceutical
technology and organisation of
national and international conferences, exhibition and similar events in areas
of mutual interest, it said.
School of Life Sciences of UoH has been
undertaking collaborative research in the areas of drug discovery for the past
several years with Natco. The research has resulted in developing one of the
molecules to Phase-II clinical trials for the treatment of chronic myeloid
leukaemia, it added.
The MoU, signed for a period of five years,
will foster the academy industry interactions by utilisation of expertise of
the faculty and infrastructural facilities for promoting anti-cancer drug
discovery research and development at Natco, it said.
Comments
Post a Comment